AP
BEAT

AHL Partners’s BioTelemetry, Inc. BEAT Stock Holding History

AHL Partners’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,492
Closed -$351K – 1353
2017
Q2 		$351K Sell
10,492
-15,603
-60% -$465K 0.01% 1000
2017
Q1 		$755K Buy
+26,095
New +$646K 0.02% 866
2016
Q4 		– Sell
-17,037
Closed -$316K – 1306
2016
Q3 		$316K Buy
+17,037
New +$321K 0.01% 970

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AHL Partners's BEAT Position: Q3 2017 in Review

AHL Partners sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 10,492 shares — an estimated $351K sold.

AHL Partners first reported a position in BEAT in Q3 2016 and held it in 3 quarters. The position peaked at $755K in Q1 2017. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

  • AHL Partners reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
  • AHL Partners sold 10,492 BioTelemetry, Inc. shares in Q3 2017, an estimated $351K.
  • AHL Partners first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 3 quarters.
  • AHL Partners's BioTelemetry, Inc. position peaked at $755K in Q1 2017.
  • 211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on AHL Partners's 13F filing for Q3 2017, filed 14 Nov 2017.